Dose-seeking Study of Pembrolizumab Plus Vemurafenib and Cobimetinib Advanced Melanoma
Clinical trial NCT02818023 · TERMINATED
Trial details
- NCT number
- NCT02818023
- Sponsor
- Yana Najjar
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-13
- Primary completion
- 2019-06-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.